Company Search:
Advanced Search
Sponsored Links
BIO-TECHNE Corp Company Snapshot
BIO-TECHNE Corp operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares BIO-TECHNE Corp with three other pharmaceutical manufacturers in North America: Myriad Genetics Inc (2019 sales of $851.10 million of which 93% was Diagnostics), Lannett Company, Inc. ($655.41 million of which 30% was Thyroid Deficiency), and Phibro Animal Health Corp ($828.00 million of which 64% was Animal Health).

Sales Analysis. BIO-TECHNE Corp reported sales of $714.01 million for the fiscal year ending June of 2019. This represents an increase of 11.0% versus 2018, when the company's sales were $642.99 million. Sales at BIO-TECHNE Corp have increased during each of the previous five years (and since 2014, sales have increased a total of 100%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
  Stock Performance Chart for BIO-TECHNE Corp
  Stock Data: Recent Stock Performance:
  Current Price (11/29/2019): 218.25
(Figures in U.S. Dollars)
1 Week 1.3%   13 Weeks 3.7%  
4 Weeks 13.9%   52 Weeks 35.2%  
BIO-TECHNE Corp Key Data:
  Ticker: TECH Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2019 Sales 714,006,000
(Year Ending Jan 2020).
Employees: 2,250
  Currency: U.S. Dollars Market Cap: 8,311,896,729
  Fiscal Yr Ends: June Shares Outstanding: 38,084,292
  Share Type: Common Closely Held Shares: 144,985
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.